In contrast, a VHL-recruiting FLT-3 PROTAC from Crews’ lab potently induced FLT-3 ITD degradation in MV4-11 and MOLM-14 AML cell lines in vitro [10]. The gene discussed is FLT3; the disease is acute myeloid leukemia.